Demystifying biologics, their biosimilars and the PBS

Update: 2021-05-18

Description

In this episode, Professor Debra Rowett is joined by Professor Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee and Dr Paul Kubler, Consultant Rheumatologist to discuss how b/tsDMARDs are funded in Australia, the policies and mechanisms that influence the cost to government and how the introduction of biosimilars affects the pricing of biologics on the PBS.

Comments

In Channel

A Round up of Resources for Inflammatory Arthritis

2022-06-2918:19

"the limbic" Podcast - Rheumatology advanced trainees. Vasculitis Pt 2: tips to overcome challenges in diagnosing and treating Giant Cell Arteritis

2021-07-2635:47

"the limbic" Podcast - Rheumatology advanced trainees - Vasculitis Pt 1: tips to overcome challenges in diagnosing and treating Giant Cell Arteritis Vasculitis

2021-07-2437:24

"the limbic" Podcast - Rheumatology advanced trainees. Flipping the fibromyalgia paradigm: how changing the way you think about chronic pain benefits patients

2021-07-2240:10

"the limbic" Podcast - Rheumatology advanced trainees. Navigating biologics – when to start, when to switch and how to handle the data

2021-07-1947:20

Demystifying biologics, their biosimilars and the PBS

2021-05-1820:15

The contemporary role of methotrexate and glucocorticoids in RA.

2021-05-0422:01

Down-Titration Living Guidelines

2021-02-2523:34